China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financi...( ...)

------------

SHAREHOLDERS' EQUITY:

Preferred stock, $0.01 par value, 10,000,000

shares authorized; 417,500 shares

Issued and outstanding 4,175

Common stock, $0.01 par value, 200,000,000 shares authorized;

36,465,312 shares issued and outstanding 364,654

Paid-in capital 13,093,750

Capital receivable (252,471)

Deferred compensation (46,125)

Statutory reserves 2,754,547

Retained earnings (deficit) (3,771,410)

Accumulated other comprehensive income 1,221,847

------------

Total shareholders' equity 13,368,967

------------

Total liabilities and shareholders' equity $ 50,053,589

============

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2007 AND 2006

Three months ended June 30,

2007 2006

------------ ------------

(Unaudited) (Unaudited)

------------ ------------

Restated

------------

REVENUES $ 8,891,559 $ 6,965,81
'/>"/>

SOURCE China Biopharmaceuticals Holdings, Inc. Copyright©2007 PR Newswire.

0 GOOD